News | April 11, 2026
Orchid Pharma submits Q4 FY26 SEBI compliance certificate to NSE, BSE
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
The collaboration brings together AIG Hospitals’ high-volume clinical expertise, advanced innovation capabilities, and growing artificial intelligence-led healthcare initiatives
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
The biggest highlight was Project Vimana, a drone-deployed battlefield trauma surgery system engineered to bring life-saving surgical intervention
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
Experts also underscored the growing role of technologies such as tele-neurorehabilitation, robotics, and AI-driven therapies in improving recovery outcomes
The nationwide campaign, running from April 9–23 highlights the first 1,000 days, nutrition, responsive caregiving and play-based learning as critical pillars for children
Subscribe To Our Newsletter & Stay Updated
